Stefan Costinean

10.2k total citations · 5 hit papers
39 papers, 7.0k citations indexed

About

Stefan Costinean is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Stefan Costinean has authored 39 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 21 papers in Cancer Research and 10 papers in Immunology. Recurrent topics in Stefan Costinean's work include MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (11 papers) and Circular RNAs in diseases (8 papers). Stefan Costinean is often cited by papers focused on MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (11 papers) and Circular RNAs in diseases (8 papers). Stefan Costinean collaborates with scholars based in United States, Italy and Türkiye. Stefan Costinean's co-authors include Carlo M. Croce, Esmerina Tili, Stefano Volinia, Nicola Zanesi, George A. Calin, Muller Fabbri, Jean‐Jacques Michaille, Yuri Pekarsky, Hansjüerg Alder and Nyla A. Heerema and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Stefan Costinean

39 papers receiving 6.9k citations

Hit Papers

MicroRNA-29 family reverts aberrant methylation in lung c... 2006 2026 2012 2019 2007 2007 2006 2012 2011 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
    2007 1.3k citations Muller Fabbri, Ramiro Garzon et al. Proceedings of the National Academy of Sciences profile →
  2. Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNF-α Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock
    2007 1.1k citations Esmerina Tili, Jean‐Jacques Michaille et al. The Journal of Immunology profile →
  3. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
    2006 795 citations Stefan Costinean, Nicola Zanesi et al. Proceedings of the National Academy of Sciences profile →
  4. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
    2012 623 citations Shu‐Hao Hsu, Bo Wang et al. Journal of Clinical Investigation profile →
  5. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer
    2011 545 citations Chiara Braconi, Takayuki Kogure et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Costinean United States 29 5.1k 4.6k 1.2k 546 453 39 7.0k
Changchun Xiao United States 32 4.7k 0.9× 4.4k 1.0× 2.6k 2.2× 754 1.4× 350 0.8× 62 7.6k
Nicola Zanesi United States 37 6.2k 1.2× 4.4k 0.9× 1.1k 0.9× 834 1.5× 263 0.6× 83 7.9k
Preethi H. Gunaratne United States 43 3.6k 0.7× 2.6k 0.6× 822 0.7× 535 1.0× 249 0.5× 131 5.4k
Calin Dan Dumitru United States 15 9.1k 1.8× 8.4k 1.8× 1.9k 1.6× 718 1.3× 371 0.8× 20 11.8k
Morten Lindow Denmark 28 5.8k 1.1× 4.9k 1.1× 501 0.4× 248 0.5× 436 1.0× 37 7.2k
Dinis Pedro Calado United Kingdom 26 3.6k 0.7× 2.9k 0.6× 2.6k 2.2× 960 1.8× 233 0.5× 42 6.5k
Enikö Sonkoly Sweden 37 2.4k 0.5× 2.3k 0.5× 1.6k 1.3× 861 1.6× 357 0.8× 70 5.4k
Salvatore Oliviero Italy 45 5.3k 1.0× 1.2k 0.3× 670 0.6× 1.2k 2.3× 381 0.8× 123 7.0k
Ji‐Fan Hu United States 44 4.6k 0.9× 1.8k 0.4× 509 0.4× 546 1.0× 396 0.9× 145 6.3k
Stefano Casola Italy 31 2.6k 0.5× 1.5k 0.3× 2.6k 2.2× 821 1.5× 476 1.1× 58 5.6k

Countries citing papers authored by Stefan Costinean

Since Specialization
Citations

This map shows the geographic impact of Stefan Costinean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Costinean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Costinean more than expected).

Fields of papers citing papers by Stefan Costinean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Costinean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Costinean. The network helps show where Stefan Costinean may publish in the future.

Co-authorship network of co-authors of Stefan Costinean

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Costinean. A scholar is included among the top collaborators of Stefan Costinean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Costinean. Stefan Costinean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haney, Staci L., Jana Opavska, David Klinkebiel, et al.. (2016). Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3a. Cell Reports. 15(6). 1190–1201. 28 indexed citations
2.
Cushing, Leah, Stefan Costinean, Wei Xu, et al.. (2015). Disruption of miR-29 Leads to Aberrant Differentiation of Smooth Muscle Cells Selectively Associated with Distal Lung Vasculature. PLoS Genetics. 11(5). e1005238–e1005238. 48 indexed citations
3.
Zhou, QiQi, Stefan Costinean, Carlo M. Croce, et al.. (2014). MicroRNA 29 Targets Nuclear Factor-κB–Repressing Factor and Claudin 1 to Increase Intestinal Permeability. Gastroenterology. 148(1). 158–169.e8. 143 indexed citations
4.
Drusco, Alessandra, Gerard J. Nuovo, Nicola Zanesi, et al.. (2014). MicroRNA Profiles Discriminate among Colon Cancer Metastasis. PLoS ONE. 9(6). e96670–e96670. 96 indexed citations
5.
Hsu, Shu‐Hao, Bo Wang, Huban Kutay, et al.. (2013). Hepatic Loss of miR-122 Predisposes Mice to Hepatobiliary Cyst and Hepatocellular Carcinoma upon Diethylnitrosamine Exposure. American Journal Of Pathology. 183(6). 1719–1730. 26 indexed citations
6.
Hsu, Shu‐Hao, Bo Wang, Janaiah Kota, et al.. (2012). Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. Journal of Clinical Investigation. 122(8). 2871–2883. 623 indexed citations breakdown →
7.
Smith, Kristen M., Mireia Guerau‐de‐Arellano, Stefan Costinean, et al.. (2012). miR-29ab1 Deficiency Identifies a Negative Feedback Loop Controlling Th1 Bias That Is Dysregulated in Multiple Sclerosis. The Journal of Immunology. 189(4). 1567–1576. 157 indexed citations
8.
Kogure, Takayuki, Stefan Costinean, Irene K. Yan, et al.. (2012). Hepatic miR‐29ab1 expression modulates chronic hepatic injury. Journal of Cellular and Molecular Medicine. 16(11). 2647–2654. 48 indexed citations
9.
Braconi, Chiara, Takayuki Kogure, Nicola Valeri, et al.. (2011). microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene. 30(47). 4750–4756. 545 indexed citations breakdown →
10.
Braconi, Chiara, Takayuki Kogure, Nicola Valeri, et al.. (2011). Abstract 1178: Involvement of MEG3, a long non-coding RNA, in hepatocellular cancer (HCC). Cancer Research. 71(8_Supplement). 1178–1178. 1 indexed citations
11.
Sandhu, Sukhinder K., et al.. (2010). Abstract 3: OncomiR-155 targets oncogenes HDAC4 and BCL6 in a murine B cell leukemia model: A paradigm shift in the oncogenic mechanisms of microRNAs. Cancer Research. 70(8_Supplement). 3–3. 9 indexed citations
12.
Drusco, Alessandra, Yuri Pekarsky, Stefan Costinean, et al.. (2010). Common Fragile Site Tumor Suppressor Genes and Corresponding MouseModels of Cancer. BioMed Research International. 2011(1). 984505–984505. 17 indexed citations
13.
Costinean, Stefan, Sukhinder K. Sandhu, Irene M. Pedersen, et al.. (2009). Src homology 2 domain–containing inositol-5-phosphatase and CCAAT enhancer-binding protein β are targeted by miR-155 in B cells of Eμ-MiR-155 transgenic mice. Blood. 114(7). 1374–1382. 235 indexed citations
14.
Güler, Gülnur, Kay Huebner, Çiğdem Himmetoğlu, et al.. (2009). Fragile histidine triad protein, WW domain‐containing oxidoreductase protein Wwox, and activator protein 2γ expression levels correlate with basal phenotype in breast cancer. Cancer. 115(4). 899–908. 40 indexed citations
15.
Visone, Rosa, Laura Z. Rassenti, Angelo Veronese, et al.. (2009). Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood. 114(18). 3872–3879. 150 indexed citations
16.
Tili, Esmerina, Jean‐Jacques Michaille, Stefan Costinean, et al.. (2007). Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNF-α Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock. The Journal of Immunology. 179(8). 5082–5089. 1110 indexed citations breakdown →
17.
Qin, Haiyan, Dimitrios Iliopoulos, Tatsuya Nakamura, et al.. (2007). Wwox Suppresses Prostate Cancer Cell Growth through Modulation of ErbB2-Mediated Androgen Receptor Signaling. Molecular Cancer Research. 5(9). 957–965. 25 indexed citations
18.
Fabbri, Muller, Ramiro Garzon, Amelia Cimmino, et al.. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proceedings of the National Academy of Sciences. 104(40). 15805–15810. 1285 indexed citations breakdown →
19.
Trapasso, Francesco, Alessandra Drusco, Stefan Costinean, et al.. (2006). Genetic Ablation of Ptprj , a Mouse Cancer Susceptibility Gene, Results in Normal Growth and Development and Does Not Predispose to Spontaneous Tumorigenesis. DNA and Cell Biology. 25(6). 376–382. 39 indexed citations
20.
Latronico, Michael V.G., et al.. (2004). Regulation of Cell Size and Contractile Function by AKT in Cardiomyocytes. Annals of the New York Academy of Sciences. 1015(1). 250–260. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changchun Xiao Breakdown of academic impact, for papers by Nicola Zanesi Breakdown of academic impact, for papers by Preethi H. Gunaratne Breakdown of academic impact, for papers by Calin Dan Dumitru Breakdown of academic impact, for papers by Morten Lindow Breakdown of academic impact, for papers by Dinis Pedro Calado Breakdown of academic impact, for papers by Enikö Sonkoly Breakdown of academic impact, for papers by Salvatore Oliviero Breakdown of academic impact, for papers by Ji‐Fan Hu Breakdown of academic impact, for papers by Stefano Casola
Rankless by CCL
2026